← Leaderboards
Douglas W. Grosenbach
Siga Technologies, Inc.
$3,614,629
Attributed
$3,614,629
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1M · FY2007–11$1M$750K$500K$250K$0
'07
'08
'09
'10
'11
Funding mix
By agency
NIH$3,614,629 · 2
By mechanism
R44$2,999,939 · 1
R43$614,690 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Vaccines”
- Lawrence Corey · Fred Hutchinson Cancer Center$829,044,908
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$556,540,832
- Bambra Strokes · Ppd Development Lp$526,656,217
- Barton F Haynes · Duke University$515,215,260
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$398,445,678
- Dennis R. Burton · Scripps Research Institute$316,106,418
Research focus
VaccinesResponseSmallpox VaccineVaccinationImmunocompetentImmune SystemPoxviridaeSmallpoxInfectionVaccinatedPharmaceutical PreparationsMonkeypoxImmunityAnimalsAdverse EventImmunologic Deficiency SyndromesPreventEmbryoOralOrthopoxvirusMonkeysAffectNonhuman PrimateInvestigational New Drug Application
Grant awards (5)
ST-246 treatment of smallpox vaccine-related adverse events$1,000,000
R44 · FY2011 · AI · contact PI
ST-246 treatment of smallpox vaccine-related adverse events$999,979
R44 · FY2010 · AI · contact PI
ST-246 treatment of smallpox vaccine-related adverse events$999,960
R44 · FY2009 · AI · contact PI
ST-246 treatment of smallpox vaccine-related adverse events in murine models$321,291
R43 · FY2008 · AI · contact PI
ST-246 treatment of smallpox vaccine-related adverse events in murine models$293,399
R43 · FY2007 · AI · contact PI